STOCK TITAN

IVRO'S Mission To Help Make Non-Animal Testing Famous Now Searches For Strategic Partners

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

PLACENTIA, CA / ACCESSWIRE / September 1, 2021 / InVitro International (OTC PINK:IVRO) announced today that it has taken a first step in its search for strategic partners. IVRO entered into Letter of Intent (LOI) discussions where, although nothing certain can be forecasted, the Company believes results could be instrumental in furthering IVRO's primary mission to "Help Make Non-Animal Testing Famous". This announcement comes on the heels of an outstanding 3rd Quarter (June 30) FY 2021, where sales rebounded 51% over 2nd Quarter, and cash on hand grew to $1.3M.

About InVitro International, Inc.

InVitro International, Inc., headquartered in Placentia, California, was founded in 1985 and is a customer and technology-driven provider of non-animal testing methods. The Company's testing technologies are designed to produce data regarding corrosivity and ocular/dermal irritation, which correlate with animal and human test results. IVRO's technology is commercialized globally through test kits and partner laboratory services.

This release may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by forward looking statements. These risks and uncertainties include but are not limited to: acceptance of the Company's technology by customers or regulatory agencies, changes in market conditions and other competitive factors. The forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update such statements.

Company Contact:

W. Richard Ulmer
Chief Executive Officer and Chairman
(800)246-8487
invitro@invitrointl.com
www.invitrointl.com

SOURCE: InVitro International



View source version on accesswire.com:
https://www.accesswire.com/662200/IVROS-Mission-To-Help-Make-Non-Animal-Testing-Famous-Now-Searches-For-Strategic-Partners

InVitro International

OTC:IVRO

IVRO Rankings

IVRO Latest News

IVRO Stock Data

911.82k
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
Placentia

About IVRO

invitro international develops test kits for non-animal testing in the united states and internationally. its products include irritection assay system, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and corrositex, an invitro test that determines chemical corrosivity. the company also provides customized technology services for irritection assay system installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. the company was founded in 1985 and is headquartered in placentia, california.